{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:46:34Z","timestamp":1792143994956,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eNeurologicalSci"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ensci.2026.100620","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:49:47Z","timestamp":1787849387000},"page":"100620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of HALP score with clinical and radiological activity following fingolimod discontinuation in patients with multiple sclerosis"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2719-0428","authenticated-orcid":false,"given":"Seyda Figul","family":"Gokce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6566-3751","authenticated-orcid":false,"given":"Asli","family":"Bolayir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9714-0672","authenticated-orcid":false,"given":"Ecem","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-9497","authenticated-orcid":false,"given":"Burhanettin","family":"Cigdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ensci.2026.100620_bb0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(08)70042-5","article-title":"Environmental factors and multiple sclerosis","volume":"7","author":"Ebers","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ensci.2026.100620_bb0010","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1080\/14656566.2017.1373093","article-title":"Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis","volume":"18","author":"Thomas","year":"2017","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.ensci.2026.100620_bb0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2015.03.022","article-title":"Severe disease reactivation in four patients with relapsing-remitting multiple sclerosis after fingolimod cessation","volume":"15","author":"Berger","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ensci.2026.100620_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.msard.2017.05.003","article-title":"Disease reactivation following fingolimod withdrawal in multiple sclerosis: two case reports","volume":"15","author":"Forci","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.ensci.2026.100620_bb0025","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40261-019-00804-6","article-title":"Severe exacerbation of multiple sclerosis following withdrawal of fingolimod","volume":"39","author":"Fragoso","year":"2019","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ensci.2026.100620_bb0030","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1111\/ene.15913","article-title":"Comparison of multiple sclerosis patients with or without rebound activity after fingolimod cessation: five-year clinical outcomes","volume":"30","author":"Gulec","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ensci.2026.100620_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12883-023-03101-0","article-title":"The role of systemic immune inflammatory index in showing active lesion in patients with multiple sclerosis: SII and other inflamatuar biomarker in radiological active multiple sclerosis patients","volume":"23","author":"Gokce","year":"2023","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ensci.2026.100620_bb0040","doi-asserted-by":"crossref","first-page":"41370","DOI":"10.18632\/oncotarget.5629","article-title":"Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ensci.2026.100620_bb0045","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/nu15051159","article-title":"Inflammation and nutrition: friend or foe?","volume":"25","author":"Stumpf","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ensci.2026.100620_bb0050","doi-asserted-by":"crossref","first-page":"10065","DOI":"10.2147\/JIR.S489502","article-title":"Inflammatory and nutritional markers as indicators for diagnosing and assessing disease activity in MS and NMOSD","volume":"29","author":"Li","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ensci.2026.100620_bb0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5152\/ArchRheumatol.2025.25012","article-title":"Immunonutritional biomarkers in primary Sj\u00f6gren\u2019s syndrome disease activity: CALLY index and HALP score","volume":"1","author":"Bircan","year":"2025","journal-title":"Arch. Rheumatol."},{"key":"10.1016\/j.ensci.2026.100620_bb0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000363515","article-title":"Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis","volume":"72","author":"Wang","year":"2014","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.ensci.2026.100620_bb0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2019.10.031","article-title":"Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study","volume":"133","author":"Eckart","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ensci.2026.100620_bb0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1186\/s40001-025-02925-5","article-title":"Dynamic association of serum albumin changes with inflammation, nutritional status and clinical outcomes: a secondary analysis of a large prospective observational cohort study","volume":"28","author":"Li","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.ensci.2026.100620_bb0075","article-title":"Albumin and multiple sclerosis: a prospective study from UK Biobank","volume":"10","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ensci.2026.100620_bb0080","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2147\/JIR.S442532","article-title":"Serum albumin level can predict immunotherapy response of neuromyelitis optica spectrum disorders in the acute phase","volume":"12","author":"Xiang","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ensci.2026.100620_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.59556\/japi.72.0496","article-title":"Role of serum calcium, serum albumin, and serum uric acid as markers of initial neurological severity and short-term outcome indicators in acute ischemic stroke","volume":"2","author":"Chinnammanavar","year":"2024","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.ensci.2026.100620_bb0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.31729\/jnma.8792","article-title":"Correlation between serum albumin level and severity of acute ischemic stroke: a cross-sectional study","volume":"62","author":"Pantha","year":"2024","journal-title":"J. Nepal Med. Assoc."},{"key":"10.1016\/j.ensci.2026.100620_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.55782\/ane-2025-2680","article-title":"Iron in multiple sclerosis \u2013 from pathophysiology to disease progression - a narrative literature review","volume":"31","author":"K\u0142odnicka","year":"2025","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.ensci.2026.100620_bb0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000381212","article-title":"Association between anemia and multiple sclerosis","volume":"73","author":"Koudriavtseva","year":"2015","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.ensci.2026.100620_bb0105","first-page":"39","article-title":"Comorbidities in multiple sclerosis-a plea for interdisciplinary collaboration to improve the quality of life of MS patients","volume":"13","author":"Goischke","year":"2019","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.ensci.2026.100620_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102374","article-title":"Inflammatory markers in systemic lupus erythematosus","volume":"110","author":"Aringer","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ensci.2026.100620_bb0115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.1255","article-title":"Immunopathology of secondary-progressive multiple sclerosis","volume":"50","author":"Prineas","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ensci.2026.100620_bb0120","article-title":"Multiple sclerosis","volume":"43","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ensci.2026.100620_bb0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/09629359890857","article-title":"The immunoregulatory abilities of polymorphonuclear neutrophils in the course of multiple sclerosis","volume":"7","author":"Ziaber","year":"1998","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ensci.2026.100620_bb0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4149\/BLL_2021_060","article-title":"The relationship between neutrophil\/lymphocyte ratio and uric acid levels in multiple sclerosis patients","volume":"122","author":"Bolayir","year":"2021","journal-title":"Bratisl. Med. J."},{"key":"10.1016\/j.ensci.2026.100620_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2016.06.017","article-title":"The contribution of neutrophils to CNS autoimmunity","volume":"189","author":"Pierson","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ensci.2026.100620_bb0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneuroim.2011.11.009","article-title":"Neutrophils in multiple sclerosis are characterized by a primed phenotype","volume":"242","author":"Naegele","year":"2012","journal-title":"J. Neuroimmunol."}],"container-title":["eNeurologicalSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650226000171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650226000171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:10:22Z","timestamp":1792141822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405650226000171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":28,"alternative-id":["S2405650226000171"],"URL":"https:\/\/doi.org\/10.1016\/j.ensci.2026.100620","relation":{},"ISSN":["2405-6502"],"issn-type":[{"value":"2405-6502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of HALP score with clinical and radiological activity following fingolimod discontinuation in patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"eNeurologicalSci","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ensci.2026.100620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100620"}}